{"id":"https://openalex.org/W4416200213","doi":"https://doi.org/10.1155/tbj/3770655","title":"Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple\u2010Negative Breast Cancer","display_name":"Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple\u2010Negative Breast Cancer","alternate_titles":[],"publication_year":2025,"publication_date":"2025-01-01","ids":{"openalex":"https://openalex.org/W4416200213","doi":"https://doi.org/10.1155/tbj/3770655","pmid":"https://pubmed.ncbi.nlm.nih.gov/41282047","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12638172"},"language":"en","primary_location":{"id":"doi:10.1155/tbj/3770655","doi":"https://doi.org/10.1155/tbj/3770655","is_oa":true,"landing_page_url":"https://doi.org/10.1155/tbj/3770655","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1155/tbj/3770655","source":{"id":"https://openalex.org/S169520197","display_name":"The Breast Journal","issn_l":"1075-122X","issn":["1075-122X","1524-4741"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4416200213"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1155/tbj/3770655","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082959086","display_name":"Zaida Morante","orcid":"https://orcid.org/0000-0003-2952-6068","observed_orcids":["https://orcid.org/0000-0003-2952-6068"]},"institutions":[{"id":"https://openalex.org/I197097402","display_name":"Universidad Peruana Cayetano Heredia","ror":"https://ror.org/03yczjf25","country_code":"PE","type":"education","lineage":["https://openalex.org/I197097402"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Zaida Morante","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","Faculty of Human Medicine, Cayetano Heredia Peruvian University, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0003-2952-6068","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]},{"raw_affiliation_string":"Faculty of Human Medicine, Cayetano Heredia Peruvian University, Lima, Peru","institution_ids":["https://openalex.org/I197097402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028821100","display_name":"Yomali Ferreyra","orcid":"https://orcid.org/0000-0002-5184-9595","observed_orcids":["https://orcid.org/0000-0002-5184-9595"]},"institutions":[{"id":"https://openalex.org/I197097402","display_name":"Universidad Peruana Cayetano Heredia","ror":"https://ror.org/03yczjf25","country_code":"PE","type":"education","lineage":["https://openalex.org/I197097402"]},{"id":"https://openalex.org/I214830159","display_name":"Universidad Privada San Juan Bautista","ror":"https://ror.org/04ytrqw44","country_code":"PE","type":"education","lineage":["https://openalex.org/I214830159"]},{"id":"https://openalex.org/I4405259621","display_name":"Instituto de Medicina Tropical Alexander von Humboldt","ror":"https://ror.org/02ffh4228","country_code":"PE","type":"facility","lineage":["https://openalex.org/I197097402","https://openalex.org/I4405259621"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Yomali Ferreyra","raw_affiliation_strings":["Health Innovation Laboratory-Institute of Tropical Medicine \"Alexander von Humboldt\", Cayetano Heredia Peruvian University, Lima, Peru","Professional School of Human Medicine, San Juan Bautista Private University, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0002-5184-9595","affiliations":[{"raw_affiliation_string":"Health Innovation Laboratory-Institute of Tropical Medicine \"Alexander von Humboldt\", Cayetano Heredia Peruvian University, Lima, Peru","institution_ids":["https://openalex.org/I197097402","https://openalex.org/I4405259621"]},{"raw_affiliation_string":"Professional School of Human Medicine, San Juan Bautista Private University, Lima, Peru","institution_ids":["https://openalex.org/I214830159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028769763","display_name":"Iris Otoya","orcid":"https://orcid.org/0000-0001-6185-9853","observed_orcids":["https://orcid.org/0000-0001-6185-9853"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Iris Otoya","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0001-6185-9853","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053786511","display_name":"Natalia Valdiviezo","orcid":"https://orcid.org/0000-0002-4300-5958","observed_orcids":["https://orcid.org/0000-0002-4300-5958"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Natalia Valdiviezo","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0002-4300-5958","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118548660","display_name":"Norma Huarcaya","orcid":"https://orcid.org/0009-0005-3290-8421","observed_orcids":["https://orcid.org/0009-0005-3290-8421"]},"institutions":[{"id":"https://openalex.org/I197097402","display_name":"Universidad Peruana Cayetano Heredia","ror":"https://ror.org/03yczjf25","country_code":"PE","type":"education","lineage":["https://openalex.org/I197097402"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Norma Huarcaya-Chombo","raw_affiliation_strings":["Faculty of Science and Engineering, Cayetano Heredia Peruvian University, Lima, Peru"],"raw_orcid":"https://orcid.org/0009-0005-3290-8421","affiliations":[{"raw_affiliation_string":"Faculty of Science and Engineering, Cayetano Heredia Peruvian University, Lima, Peru","institution_ids":["https://openalex.org/I197097402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104701696","display_name":"Gabriela Polo-Mendoza","orcid":"https://orcid.org/0000-0003-2481-3463","observed_orcids":["https://orcid.org/0000-0003-2481-3463"]},"institutions":[{"id":"https://openalex.org/I4210144718","display_name":"Universidad de Ingenier\u00eda y Tecnolog\u00eda","ror":"https://ror.org/040gykh71","country_code":"PE","type":"education","lineage":["https://openalex.org/I4210144718"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Gabriela Polo-Mendoza","raw_affiliation_strings":["Department of Bioengineering, University of Engineering and Technology, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0003-2481-3463","affiliations":[{"raw_affiliation_string":"Department of Bioengineering, University of Engineering and Technology, Lima, Peru","institution_ids":["https://openalex.org/I4210144718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101347293","display_name":"Cindy Calle","orcid":"https://orcid.org/0009-0008-1502-4407","observed_orcids":["https://orcid.org/0009-0008-1502-4407"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Cindy Calle","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0009-0008-1502-4407","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075211096","display_name":"Jessica Meza-Liviapoma","orcid":"https://orcid.org/0000-0001-8057-7093","observed_orcids":["https://orcid.org/0000-0001-8057-7093"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Jessica Meza","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0001-8057-7093","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020219644","display_name":"Carlos Arturo Casta\u00f1eda","orcid":"https://orcid.org/0000-0001-6200-0856","observed_orcids":["https://orcid.org/0000-0001-6200-0856"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Carlos Casta\u00f1eda","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0001-6200-0856","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019516323","display_name":"Tatiana Vidaurre","orcid":"https://orcid.org/0000-0003-1995-4560","observed_orcids":["https://orcid.org/0000-0003-1995-4560"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Tatiana Vidaurre","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0003-1995-4560","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083463054","display_name":"Guillermo Valencia","orcid":"https://orcid.org/0000-0002-4234-4448","observed_orcids":["https://orcid.org/0000-0002-4234-4448"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Guillermo Valencia","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0002-4234-4448","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002304475","display_name":"Patricia Rioja","orcid":"https://orcid.org/0000-0003-3141-7418","observed_orcids":["https://orcid.org/0000-0003-3141-7418"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Patricia Rioja","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0003-3141-7418","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072481563","display_name":"Hugo Alejandro Fuentes","orcid":"https://orcid.org/0000-0002-2747-7381","observed_orcids":["https://orcid.org/0000-0002-2747-7381"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Hugo Fuentes","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0002-2747-7381","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024747592","display_name":"Silvia P. Neciosup","orcid":"https://orcid.org/0000-0002-2657-9853","observed_orcids":["https://orcid.org/0000-0002-2657-9853"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Silvia P. Neciosup","raw_affiliation_strings":["Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0002-2657-9853","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049679970","display_name":"Henry G\u00f3mez","orcid":"https://orcid.org/0000-0002-3415-9701","observed_orcids":["https://orcid.org/0000-0002-3415-9701","https://orcid.org/0000-0003-2660-1843"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Henry L. Gomez","raw_affiliation_strings":["Oncosalud, Auna Ideas, Lima, Peru"],"raw_orcid":"https://orcid.org/0000-0003-2660-1843","affiliations":[{"raw_affiliation_string":"Oncosalud, Auna Ideas, Lima, Peru","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5049679970"],"corresponding_institution_ids":[],"apc_list":{"value":2350,"currency":"USD","value_usd":2350},"apc_paid":{"value":2350,"currency":"USD","value_usd":2350},"fwci":0.5472,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.55684624,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"2025","issue":"1","first_page":"3770655","last_page":"3770655"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9355000257492065,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9355000257492065,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.06120000034570694,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/her2-status","display_name":"HER2 status","score":0.9020000100135803},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9419999718666077},{"id":"https://openalex.org/keywords/her2-low","display_name":"HER2-low","score":0.7630000114440918},{"id":"https://openalex.org/keywords/her2-negative","display_name":"HER2-negative","score":0.8420000076293945},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9800000190734863},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9819999933242798},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7590000033378601},{"id":"https://openalex.org/keywords/peruvian-patients","display_name":"Peruvian patients","score":0.9549999833106995},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6230000257492065},{"id":"https://openalex.org/keywords/clinicopathological-features","display_name":"clinicopathological features","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8891000151634216},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7335000038146973},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7081999778747559},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6951000094413757},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6197999715805054},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.45750001072883606},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.37529999017715454},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30959999561309814},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.28139999508857727},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2784000039100647},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.2741999924182892},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2734000086784363},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.2590999901294708},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25760000944137573}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010568","descriptor_name":"Peru","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1155/tbj/3770655","doi":"https://doi.org/10.1155/tbj/3770655","is_oa":true,"landing_page_url":"https://doi.org/10.1155/tbj/3770655","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1155/tbj/3770655","source":{"id":"https://openalex.org/S169520197","display_name":"The Breast Journal","issn_l":"1075-122X","issn":["1075-122X","1524-4741"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast Journal","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11445088","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12638172","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:41282047","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41282047","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The breast journal","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12638172","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12638172/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast J","raw_type":"Text"},{"id":"pmh:oai:repositorio.upch.edu.pe:20.500.12866/19678","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/20.500.12866/19678","pdf_url":null,"source":{"id":"https://openalex.org/S7407055323","display_name":"Universidad Peruana Cayetano Heredia Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:oai:doaj.org/article:cfb6cb0bac8b4613abe07cbaf6dd035e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cfb6cb0bac8b4613abe07cbaf6dd035e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Breast Journal, Vol 2025 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1155/tbj/3770655","doi":"https://doi.org/10.1155/tbj/3770655","is_oa":true,"landing_page_url":"https://doi.org/10.1155/tbj/3770655","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1155/tbj/3770655","source":{"id":"https://openalex.org/S169520197","display_name":"The Breast Journal","issn_l":"1075-122X","issn":["1075-122X","1524-4741"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416200213.pdf","grobid_xml":"https://content.openalex.org/works/W4416200213.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1737947457","https://openalex.org/W2053154970","https://openalex.org/W2089041626","https://openalex.org/W2097255042","https://openalex.org/W2101979288","https://openalex.org/W2151552902","https://openalex.org/W2430731787","https://openalex.org/W2506610626","https://openalex.org/W2562927583","https://openalex.org/W2586337333","https://openalex.org/W2887764459","https://openalex.org/W2890253514","https://openalex.org/W3033869790","https://openalex.org/W3037816974","https://openalex.org/W3080376154","https://openalex.org/W3120997246","https://openalex.org/W3128646645","https://openalex.org/W3160468108","https://openalex.org/W3179156059","https://openalex.org/W4200028620","https://openalex.org/W4207050061","https://openalex.org/W4281640394","https://openalex.org/W4282979821","https://openalex.org/W4297963537","https://openalex.org/W4306882633","https://openalex.org/W4312129650","https://openalex.org/W4321612614","https://openalex.org/W4324144375","https://openalex.org/W4361268148","https://openalex.org/W4363675655","https://openalex.org/W4378781718","https://openalex.org/W4381194465","https://openalex.org/W4381597844","https://openalex.org/W4381997532","https://openalex.org/W4383893554"],"related_works":["https://openalex.org/W4403252133","https://openalex.org/W2999087386","https://openalex.org/W2740803179","https://openalex.org/W4280631445","https://openalex.org/W4404766543","https://openalex.org/W7162002085","https://openalex.org/W4387808432","https://openalex.org/W4381997532","https://openalex.org/W4399122146","https://openalex.org/W2168286888"],"abstract_inverted_index":{"Background":[0],"Lack":[1],"of":[2,125,174,178],"human":[3],"epidermal":[4],"growth":[5],"factor":[6],"receptor":[7],"2":[8],"(HER2)":[9],"expression":[10],"limits":[11],"targeted":[12],"treatments":[13],"for":[14,247,261],"triple\u2010negative":[15],"breast":[16],"cancer":[17],"(TNBC).":[18],"HER2":[19,45,98,117,126,150,168,201,254],"status":[20,46,99,151,169,255],"changes":[21,127],"after":[22,49],"neoadjuvant":[23,267],"chemotherapy":[24],"(NAC)":[25],"have":[26],"been":[27],"reported,":[28],"but":[29],"their":[30],"impact":[31,124],"on":[32,128],"survival":[33,60,130,134],"in":[34,172,198],"Peruvian":[35],"TNBC":[36,70,138,264],"patients":[37,71,180,199,262],"remains":[38],"unexplored.":[39],"Here,":[40],"we":[41],"aimed":[42],"to":[43,93],"assess":[44,94],"before":[47],"and":[48,51,59,75,102,115,132,145,164,176,211,223,236],"NAC":[50],"its":[52],"association":[53,96],"with":[54,155,200,241,263,266],"clinical":[55],"characteristics,":[56],"treatment":[57],"response,":[58],"outcomes.":[61],"Methods":[62],"Our":[63],"analysis":[64,109,121],"included":[65],"clinicopathological":[66],"data":[67],"from":[68],"159":[69],"diagnosed":[72],"between":[73,97,113],"2015":[74],"2019":[76],"at":[77,100,143],"the":[78,95,111,123],"Instituto":[79],"Nacional":[80],"de":[81],"Enfermedades":[82],"Neopl\u00e1sicas":[83],"(Lima,":[84],"Peru)":[85],"who":[86],"received":[87],"NAC.":[88],"Logistic":[89],"regression":[90],"was":[91,152],"used":[92],"diagnosis":[101,144],"pathological":[103],"complete":[104],"response":[105],"(pCR).":[106],"Cohen\u2019s":[107],"Kappa":[108],"evaluated":[110],"agreement":[112],"pre\u2010":[114],"post\u2010NAC":[116],"status,":[118],"while":[119],"Kaplan\u2013Meier":[120],"estimated":[122],"overall":[129],"(OS)":[131],"disease\u2010free":[133],"(DFS)":[135],"Results":[136],"Among":[137],"patients,":[139],"40.3%":[140],"were":[141,196,245],"HER2\u2010low":[142,179],"14.9%":[146],"achieved":[147],"pCR.":[148],"Pretherapeutic":[149],"not":[153,258],"associated":[154],"pCR":[156],"(OR":[157],"=":[158,162,166,187,205,209,213,217,221,225,230,234,238],"1.4,":[159],"95%":[160,207,219,232],"CI":[161,208,220,233],"0.55\u20133.61,":[163],"p":[165,189,212,224,237],"0.5).":[167],"remained":[170],"unchanged":[171],"62.8%":[173],"HER2\u2010zero":[175],"75.9%":[177],"post\u2010NAC,":[181],"showing":[182],"moderate":[183],"concordance":[184],"(Cohen\u2019s":[185],"kappa":[186],"0.3418,":[188],"<":[190],"0.001).":[191],"No":[192],"significant":[193],"OS":[194],"improvements":[195],"observed":[197],"transitions:":[202],"HER2\u2010zero/HER2\u2010low":[203],"(HR":[204,216,229],"0.52,":[206],"0.22\u20131.24,":[210],"0.14),":[214],"HER2\u2010low/HER2\u2010zero":[215],"0.9,":[218],"0.34\u20132.40,":[222],"0.8),":[226],"or":[227],"HER2\u2010low/HER2\u2010low":[228],"0.71,":[231],"0.34\u20131.49,":[235],"0.4)":[239],"compared":[240],"HER2\u2010zero/HER2\u2010zero.":[242],"Similar":[243],"findings":[244,251],"reported":[246],"DFS.":[248],"Conclusion":[249],"These":[250],"suggest":[252],"that":[253],"conversion":[256],"may":[257],"be":[259],"prognostic":[260],"treated":[265],"therapy.":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4416200213","counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-11-14T00:00:00"}
